PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
 
Infect Immun. 1991 September; 59(9): 3126–3133.
PMCID: PMC258143

Activation of bovine neutrophils by partially purified Pasteurella haemolytica leukotoxin.

Abstract

In this study we developed a new method for the partial purification of Pasteurella haemolytica leukotoxin by size-exclusion high-performance liquid chromatography. The partially purified leukotoxin had a molecular weight of 104,000, as estimated by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and reacted on an immunoblot with an antileukotoxin monoclonal antibody. As expected, high concentrations of the leukotoxin were inhibitory or lethal to bovine neutrophils. Incubation of bovine neutrophils with diluted leukotoxin, however, resulted in significant neutrophil activation that was comparable in magnitude to that obtained with standard activating agents such as opsonized zymosan or zymosan-activated serum. Dilute leukotoxin (1:128 to 1:8,192 dilutions) stimulated an oxidative burst (luminol-dependent chemiluminescence) by bovine neutrophils that was comparable in magnitude to that obtained with opsonized zymosan. Preincubation with leukotoxin did not significantly prime the neutrophils for an enhanced oxidative burst when they were then exposed to opsonized zymosan as a second stimulus. Dilute leukotoxin (1:100 to 1:1,000 dilutions) also stimulated cytoskeletal alterations in bovine neutrophils, as measured by a significant shape change response. Preferential release of secondary granule constituents (lactoferrin) occurred when neutrophils were incubated with 1:100 to 1:500 dilutions of leukotoxin. Significant release of primary granules, as measured by beta-glucosaminidase activity, was not observed except at low dilutions (1:20) of leukotoxin that resulted in significant release of cytosolic constituents (i.e., lactate dehydrogenase activity). The neutrophil-activating activity of the leukotoxin was heat labile, unaffected by polymyxin B, and abrogated by a leukotoxin-neutralizing monoclonal antibody. These data indicate that P. haemolytica leukotoxin, like the closely related Escherichia coli hemolysin, is a potent neutrophil-activating agent. Leukotoxin-stimulated release of neutrophil oxygen intermediates and granule constituents may contribute to the intense inflammation that characterizes bovine pulmonary pasteurellosis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Baluyut CS, Simonson RR, Bemrick WJ, Maheswaran SK. Interaction of Pasteurella haemolytica with bovine neutrophils: identification and partial characterization of a cytotoxin. Am J Vet Res. 1981 Nov;42(11):1920–1926. [PubMed]
  • Benz R, Schmid A, Wagner W, Goebel W. Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates. Infect Immun. 1989 Mar;57(3):887–895. [PMC free article] [PubMed]
  • Berggren KA, Baluyut CS, Simonson RR, Bemrick WJ, Maheswaran SK. Cytotoxic effects of Pasteurella haemolytica on bovine neutrophils. Am J Vet Res. 1981 Aug;42(8):1383–1388. [PubMed]
  • Bhakdi S, Greulich S, Muhly M, Eberspächer B, Becker H, Thiele A, Hugo F. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J Exp Med. 1989 Mar 1;169(3):737–754. [PMC free article] [PubMed]
  • Bhakdi S, Mackman N, Nicaud JM, Holland IB. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect Immun. 1986 Apr;52(1):63–69. [PMC free article] [PubMed]
  • Breider MA, Walker RD, Hopkins FM, Schultz TW, Bowersock TL. Pulmonary lesions induced by Pasteurella haemolytica in neutrophil sufficient and neutrophil deficient calves. Can J Vet Res. 1988 Apr;52(2):205–209. [PMC free article] [PubMed]
  • Cavalieri SJ, Bohach GA, Snyder IS. Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity. Microbiol Rev. 1984 Dec;48(4):326–343. [PMC free article] [PubMed]
  • Cavalieri SJ, Snyder IS. Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro. Infect Immun. 1982 Sep;37(3):966–974. [PMC free article] [PubMed]
  • Chang YF, Young R, Moulds TL, Struck DK. Secretion of the Pasteurella leukotoxin by Escherichia coli. FEMS Microbiol Lett. 1989 Jul 15;51(1):169–173. [PubMed]
  • Chang YF, Young R, Post D, Struck DK. Identification and characterization of the Pasteurella haemolytica leukotoxin. Infect Immun. 1987 Oct;55(10):2348–2354. [PMC free article] [PubMed]
  • Chang YF, Renshaw HW. Pasteurella haemolytica leukotoxin: comparison of 51chromium-release, trypan blue dye exclusion, and luminol-dependent chemiluminescence-inhibition assays for sensitivity in detecting leukotoxin activity. Am J Vet Res. 1986 Jan;47(1):134–138. [PubMed]
  • Chang YF, Renshaw HW, Augustine JL. Bovine pneumonic pasteurellosis: chemiluminescent response of bovine peripheral blood leukocytes to living and killed Pasteurella haemolytica, Pasteurella multocida, and Escherichia coli. Am J Vet Res. 1985 Nov;46(11):2266–2271. [PubMed]
  • Clinkenbeard KD, Mosier DA, Confer AW. Transmembrane pore size and role of cell swelling in cytotoxicity caused by Pasteurella haemolytica leukotoxin. Infect Immun. 1989 Feb;57(2):420–425. [PMC free article] [PubMed]
  • Clinkenbeard KD, Mosier DA, Confer AW. Effects of Pasteurella haemolytica leukotoxin on isolated bovine neutrophils. Toxicon. 1989;27(7):797–804. [PubMed]
  • Clinkenbeard KD, Mosier DA, Timko AL, Confer AW. Effects of Pasteurella haemolytica leukotoxin on cultured bovine lymphoma cells. Am J Vet Res. 1989 Feb;50(2):271–275. [PubMed]
  • Confer AW, Panciera RJ, Mosier DA. Bovine pneumonic pasteurellosis: immunity to Pasteurella haemolytica. J Am Vet Med Assoc. 1988 Nov 15;193(10):1308–1316. [PubMed]
  • Confer AW, Simons KR. Effects of Pasteurella haemolytica lipopolysaccharide on selected functions of bovine leukocytes. Am J Vet Res. 1986 Jan;47(1):154–157. [PubMed]
  • Czuprynski CJ, Hamilton HL, Noel EJ. Ingestion and killing of Pasteurella haemolytica A1 by bovine neutrophils in vitro. Vet Microbiol. 1987 May;14(1):61–74. [PubMed]
  • Czuprynski CJ, Noel EJ. Influence of Pasteurella haemolytica A1 crude leukotoxin on bovine neutrophil chemiluminescence. Infect Immun. 1990 May;58(5):1485–1487. [PMC free article] [PubMed]
  • Devenish J, Rosendal S, Johnson R, Hubler S. Immunoserological comparison of 104-kilodalton proteins associated with hemolysis and cytolysis in Actinobacillus pleuropneumoniae, Actinobacillus suis, Pasteurella haemolytica, and Escherichia coli. Infect Immun. 1989 Oct;57(10):3210–3213. [PMC free article] [PubMed]
  • Eberspächer B, Hugo F, Bhakdi S. Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin. Infect Immun. 1989 Mar;57(3):983–988. [PMC free article] [PubMed]
  • Forestier C, Welch RA. Nonreciprocal complementation of the hlyC and lktC genes of the Escherichia coli hemolysin and Pasteurella haemolytica leukotoxin determinants. Infect Immun. 1990 Mar;58(3):828–832. [PMC free article] [PubMed]
  • Gadeberg OV, Blom J. Morphological study of the in vitro cytotoxic effect of alpha-hemolytic E. coli bacteria and culture supernatants on human blood granulocytes and monocytes. Acta Pathol Microbiol Immunol Scand B. 1986 Apr;94(2):75–83. [PubMed]
  • Gadeberg OV, Orskov I. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Infect Immun. 1984 Jul;45(1):255–260. [PMC free article] [PubMed]
  • Gentry MJ, Confer AW, Weinberg ED, Homer JT. Cytotoxin (leukotoxin) production by Pasteurella haemolytica: requirement for an iron-containing compound. Am J Vet Res. 1986 Sep;47(9):1919–1923. [PubMed]
  • Gerbig DG, Jr, Walker RD, Baker JC, Foster JS, Moore RN. Calcium ion involvement in the action of Pasteurella haemolytica leukotoxin. Vet Microbiol. 1989 Apr;19(4):325–335. [PubMed]
  • Greer CN, Shewen PE. Automated colorimetric assay for the detection of Pasteurella haemolytica leucotoxin. Vet Microbiol. 1986 Jun;12(1):33–42. [PubMed]
  • Henricks PA, Binkhorst GJ, Drijver AA, Van der Vliet H, Nijkamp FP. The effect of Pasteurella haemolytica cytotoxin on bovine polymorphonuclear leukocytes can be attenuated by beta-adrenoceptor antagonists. Vet Microbiol. 1990 Apr;22(2-3):259–266. [PubMed]
  • Kolodrubetz D, Dailey T, Ebersole J, Kraig E. Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans. Infect Immun. 1989 May;57(5):1465–1469. [PMC free article] [PubMed]
  • König B, König W, Scheffer J, Hacker J, Goebel W. Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect Immun. 1986 Dec;54(3):886–892. [PMC free article] [PubMed]
  • Lalonde G, McDonald TV, Gardner P, O'Hanley PD. Identification of a hemolysin from Actinobacillus pleuropneumoniae and characterization of its channel properties in planar phospholipid bilayers. J Biol Chem. 1989 Aug 15;264(23):13559–13564. [PubMed]
  • Lo RY, Shewen PE, Strathdee CA, Greer CN. Cloning and expression of the leukotoxin gene of Pasteurella haemolytica A1 in Escherichia coli K-12. Infect Immun. 1985 Dec;50(3):667–671. [PMC free article] [PubMed]
  • Lo RY, Strathdee CA, Shewen PE. Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1. Infect Immun. 1987 Sep;55(9):1987–1996. [PMC free article] [PubMed]
  • Mosier DA, Simons KR, Confer AW, Panciera RJ, Clinkenbeard KD. Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis. Infect Immun. 1989 Mar;57(3):711–716. [PMC free article] [PubMed]
  • Rejman JJ, Hurley WL, Bahr JM. Enzyme-linked immunosorbent assays of bovine lactoferrin and a 39-kilodalton protein found in mammary secretions during involution. J Dairy Sci. 1989 Feb;72(2):555–560. [PubMed]
  • Sample AK, Czuprynski CJ. Priming and stimulation of bovine neutrophils by recombinant human interleukin-1 alpha and tumor necrosis factor alpha. J Leukoc Biol. 1991 Feb;49(2):107–115. [PubMed]
  • Shewen PE, Wilkie BN. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect Immun. 1982 Jan;35(1):91–94. [PMC free article] [PubMed]
  • Shewen PE, Wilkie BN. Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica. Can J Vet Res. 1988 Jan;52(1):30–36. [PMC free article] [PubMed]
  • Slocombe RF, Malark J, Ingersoll R, Derksen FJ, Robinson NE. Importance of neutrophils in the pathogenesis of acute pneumonic pasteurellosis in calves. Am J Vet Res. 1985 Nov;46(11):2253–2258. [PubMed]
  • Strathdee CA, Lo RY. Extensive homology between the leukotoxin of Pasteurella haemolytica A1 and the alpha-hemolysin of Escherichia coli. Infect Immun. 1987 Dec;55(12):3233–3236. [PMC free article] [PubMed]
  • Strathdee CA, Lo RY. Regulation of expression of the Pasteurella haemolytica leukotoxin determinant. J Bacteriol. 1989 Nov;171(11):5955–5962. [PMC free article] [PubMed]
  • Styrt B, Walker RD, Dahl LD, Potter A. Time and temperature dependence of granulocyte damage by leucotoxic supernatants from Pasteurella haemolytica A1. J Gen Microbiol. 1990 Nov;136(11):2173–2178. [PubMed]
  • Styrt B, Walker RD, White JC, Dahl LD, Baker JC. Granulocyte plasma membrane damage by leukotoxic supernatant from Pasteurella haemolytica A1 and protection by immune serum. Can J Vet Res. 1990 Jan;54(1):146–150. [PMC free article] [PubMed]
  • Whiteley LO, Maheswaran SK, Weiss DJ, Ames TR. Immunohistochemical localization of Pasteurella haemolytica A1-derived endotoxin, leukotoxin, and capsular polysaccharide in experimental bovine Pasteurella pneumonia. Vet Pathol. 1990 May;27(3):150–161. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)